Therapeutic approach of repeated transient blood-brain barrier opening in amyotrophic lateral sclerosis
APHP230845
Phase 2 other active
Quick answer
Therapeutic approach of repeated transient blood-brain barrier opening in amyotrophic lateral sclerosis for Amyotrophic lateral Sclerosis is a Phase 2 program (other) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- Amyotrophic lateral Sclerosis
- Phase
- Phase 2
- Modality
- other
- Status
- active